Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

KIAA0895L_4931428F04Rik Inhibitors

KIAA0895L_4931428F04Rik inhibitors belong to a class of chemical compounds that specifically target and inhibit the activity of the KIAA0895L protein, also referred to by its mouse ortholog 4931428F04Rik. The KIAA0895L gene encodes a protein that plays a role in various cellular processes, although its precise biological function remains under investigation. Inhibition of this protein can impact signaling pathways, protein-protein interactions, and downstream molecular effects within cells. These inhibitors are designed to selectively bind to KIAA0895L, reducing its activity and consequently modulating the cellular processes it regulates.

The chemical structures of KIAA0895L_4931428F04Rik inhibitors are characterized by distinct motifs that facilitate selective binding to their target. These inhibitors may vary in terms of their molecular backbone, stereochemistry, and functional groups, which influence their affinity, specificity, and mechanism of action against the KIAA0895L protein. Through biochemical assays, the activity of these inhibitors is often studied to understand their effects on cellular mechanisms such as transcriptional regulation, metabolic processes, or cell differentiation. The design of KIAA0895L inhibitors typically involves structure-based drug design principles, with structural biology and computational chemistry contributing to optimizing their binding properties. Thus, the molecular design of KIAA0895L_4931428F04Rik inhibitors emphasizes precision in targeting the protein's active or regulatory sites, ensuring effective modulation of its function in cellular contexts.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$40.00
$73.00
$217.00
$242.00
$724.00
$1196.00
39
(2)

Stabilizes microtubules and prevents their disassembly, potentially altering MATCAP1 activity due to changes in microtubule dynamics.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$58.00
$83.00
$140.00
$242.00
38
(2)

A microtubule-depolymerizing agent that disrupts microtubule networks, possibly affecting MATCAP1 by altering substrate availability.

Colchicine

64-86-8sc-203005
sc-203005A
sc-203005B
sc-203005C
sc-203005D
sc-203005E
1 g
5 g
50 g
100 g
500 g
1 kg
$98.00
$315.00
$2244.00
$4396.00
$17850.00
$34068.00
3
(2)

Binds tubulin, leading to microtubule depolymerization, potentially impacting MATCAP1 through modified microtubule dynamics.

Vinblastine

865-21-4sc-491749
sc-491749A
sc-491749B
sc-491749C
sc-491749D
10 mg
50 mg
100 mg
500 mg
1 g
$100.00
$230.00
$450.00
$1715.00
$2900.00
4
(0)

Disrupts microtubule assembly, possibly affecting MATCAP1 action by altering the microtubule structures it associates with.

Podophyllotoxin

518-28-5sc-204853
100 mg
$82.00
1
(1)

Inhibits tubulin polymerization into microtubules, potentially affecting MATCAP1 by disrupting its microtubule-associated functions.

Eribulin

253128-41-5sc-507547
5 mg
$865.00
(0)

Inhibits the growth phase of microtubule dynamics, which could affect MATCAP1 by altering microtubule stability.

Griseofulvin

126-07-8sc-202171A
sc-202171
sc-202171B
5 mg
25 mg
100 mg
$83.00
$216.00
$586.00
4
(2)

Disrupts microtubule function by binding to tubulin, potentially impacting MATCAP1 by interfering with microtubule-dependent processes.

Docetaxel

114977-28-5sc-201436
sc-201436A
sc-201436B
5 mg
25 mg
250 mg
$85.00
$325.00
$1072.00
16
(1)

Promotes microtubule assembly and stabilizes microtubules, potentially affecting MATCAP1 through changes in microtubule dynamics.

Laulimalide

115268-43-4sc-507261
100 µg
$200.00
(0)

Binds to microtubules and stabilizes them, which could influence MATCAP1 activity due to altered microtubule structure.